Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging
Evaluation of Hyperfine Low Field Strength Portable Point-of-Care Magnetic Resonance Imaging System in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging
1 other identifier
interventional
100
1 country
1
Brief Summary
Participants with known or suspected hydrocephalus will receive brain scans using the Hyperfine, low field strength, portable, magnetic resonance imaging (MRI) system in addition to their scheduled outpatient standard of care clinical computed tomography (CT) or MRI scan. The purpose of this pilot study is to evaluate the feasibility and acceptability of using the Hyperfine system in an outpatient setting and to compare its diagnostic performance to standard clinical imaging. Outpatients with other known or suspected neurological disorders or conditions prompting routine clinical brain imaging with MRI or CT will also be enrolled and the diagnostic performance of low field scans compared to that of the same day standard of care clinical imaging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 28, 2019
CompletedFirst Submitted
Initial submission to the registry
June 10, 2020
CompletedFirst Posted
Study publicly available on registry
June 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
May 5, 2026
May 1, 2025
7.6 years
June 10, 2020
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Presence of hydrocephalus
Presence or absence of hydrocephalus will be determined qualitatively based on neuroradiologist interpretation of low-field MRI scans and companion standard clinical MRI or CT scans to evaluate performance using the low-field device to make this determination.
Through study completion, an average of 60 minutes
Quantitative ventricular volumes
Quantitative ventricular volumes (mL) will be obtained and compared for low-field and companion standard clinical MRI scans.
Through study completion, an average of 60 minutes
Presence of other important imaging findings
Presence of other important imaging findings will be determined qualitatively based on neuroradiologist interpretation of low-field MRI scans and companion standard clinical MRI or CT scans.
Through study completion, an average of 60 minutes
Study Arms (2)
Outpatients with known or suspected hydrocephalus
EXPERIMENTALOutpatients with other known or suspected neurological condition
EXPERIMENTALInterventions
Participants receive a Hyperfine low field strength brain MRI scan in addition to a regularly scheduled standard clinical CT or MRI scan.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Suspected or confirmed diagnosis of hydrocephalus from Penn referring physician
- Other suspected or confirmed neurological disorder from Penn referring physician
- Routine clinical CT or MRI of the brain scheduled/obtained on the same day as Hyperfine imaging.
- Informed consent obtained from patient or legally authorized representative
You may not qualify if:
- Contraindications to routine 1.5T MRI evaluation, including electrical implants such as cardiac pacemakers or perfusion pumps, ferromagnetic implants such as aneurysm clips, surgical clips, protheses, artificial hearts or heart valves with steel parts, metal fragments, shrapnel, tattoos near the eye, steel implants, or other irremovable ferromagnetic objects
- History of uncontrolled seizures
- Claustrophobia
- Weight greater than or equal to 400lbs (181.4kg)
- Pregnancy
- Inability or suspected inability to comply with the study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Radiology
Study Record Dates
First Submitted
June 10, 2020
First Posted
June 17, 2020
Study Start
June 28, 2019
Primary Completion (Estimated)
January 30, 2027
Study Completion (Estimated)
January 31, 2027
Last Updated
May 5, 2026
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share